BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10569508)

  • 1. Lowering the age for routine influenza vaccination to 50 years: AAFP leads the nation in influenza vaccine policy. American Academy of Family Physicians.
    Zimmerman RK
    Am Fam Physician; 1999 Nov; 60(7):2061-6, 2069-70. PubMed ID: 10569508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of influenza by expanded ages for routine vaccination.
    Zimmerman RK
    J Fam Pract; 2000 Sep; 49(9 Suppl):S15-21. PubMed ID: 11032189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza, influenza vaccine, and amantadine/rimantadine.
    Zimmerman RK; Ruben FL; Ahwesh ER
    J Fam Pract; 1997 Aug; 45(2):107-22; quiz 123-4. PubMed ID: 9267368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1007-12. PubMed ID: 15525897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2008 Apr; 121(4):e1016-31. PubMed ID: 18381500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.
    Nichol KL; Margolis KL; Wuorenma J; Von Sternberg T
    N Engl J Med; 1994 Sep; 331(12):778-84. PubMed ID: 8065407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the National Health Interview Survey: time trends in influenza vaccinations among targeted adults.
    Pleis JR; Gentleman JF
    Eff Clin Pract; 2002; 5(3 Suppl):E3. PubMed ID: 12166924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons.
    Szucs TD; Müller D
    Vaccine; 2005 Oct; 23(43):5055-63. PubMed ID: 16046035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of influenza: recommendations for influenza immunization of children, 2006-2007.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Apr; 119(4):846-51. PubMed ID: 17403861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB; Rose DN
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting the influenza vaccination of high risk adults in Hawai'i.
    Davis JW; Fujimoto RY; Chan H; Juarez DT
    Hawaii Med J; 2009 Apr; 68(3):50-4. PubMed ID: 19441613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of influenza vaccination in working-age cancer patients.
    Avritscher EB; Cooksley CD; Geraci JM; Bekele BN; Cantor SB; Rolston KV; Elting LS
    Cancer; 2007 Jun; 109(11):2357-64. PubMed ID: 17457827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of vaccination against influenza in healthy, working adults.
    Nichol KL; Lind A; Margolis KL; Murdoch M; McFadden R; Hauge M; Magnan S; Drake M
    N Engl J Med; 1995 Oct; 333(14):889-93. PubMed ID: 7666874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
    Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
    Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State-specific influenza vaccination coverage among adults--United States, 2006-07 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(38):1033-9. PubMed ID: 18818582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.
    Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ
    Am J Prev Med; 2006 Jul; 31(1):72-9. PubMed ID: 16777545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccination coverage rates in Germany a population-based cross-sectional analysis of the seasons 2002/2003 and 2003/2004.
    Müller D; Wutzler P; Szucs TD
    Med Klin (Munich); 2005 Jan; 100(1):6-13. PubMed ID: 15654537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent changes in influenza epidemiology and vaccination recommendations.
    Zimmerman RK
    J Fam Pract; 2005 Jan; 54(1 Suppl):S1-8. PubMed ID: 15623391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.